$6.18
-0.06[-0.96%]
At close: Apr 26
$6.18
0[0.00%]
After Hours: 5:07PM EDT
C4 Therapeutics
(NASDAQ:CCCC)C4 Therapeutics Stock (NASDAQ:CCCC), Insider Trading Activity
C4 Therapeutics: Insider buying and selling updated today.
Insider Shares Owned
1.397M
Insider Percentage Owned
2.04%
Institutional Shares Held
22.674M
Institutional Percentage Held
33.1%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2023 | Utpal Koppikar | DIRECTOR | 5.667K | $5.60 | $31.74K | BUY | ∞ | 5.667K | Feb 08 | View |
| Apr 12, 2022 | Andrew Hirsch | PRESIDENT & CEO | 10K | $8.40 | $84.00K | BUY | ∞ | 10K | Apr 12 | View |
| Jan 05, 2022 | Adam Crystal | CHIEF MEDICAL OFFICER | 0 | $19.08 | -$377.62K | SELL-OPTIONS | 0.00% | 15K | Jan 04 | View |
| Dec 17, 2021 | Malcolm Salter | DIRECTOR | -755 | $30.25 | -$22.84K | SELL | -6.45% | 10.952K | Dec 17 | View |
| Nov 19, 2021 | Malcolm Salter | DIRECTOR | -755 | $40.11 | -$30.28K | SELL | -6.06% | 11.707K | Nov 19 | View |
| Oct 15, 2021 | Malcolm Salter | DIRECTOR | -755 | $44.94 | -$33.93K | SELL | -5.71% | 12.462K | Oct 15 | View |
| Oct 05, 2021 | Adam Crystal | CHIEF MEDICAL OFFICER | 0 | $25.20 | -$606.74K | SELL-OPTIONS | 0.00% | 0 | Oct 01 | View |
| Sep 29, 2021 | Elena Prokupets | DIRECTOR | -1.85K | $50.04 | -$92.57K | SELL | -0.37% | 503.126K | Sep 27 | View |
| Sep 24, 2021 | Elena Prokupets | DIRECTOR | -32.743K | $50.28 | -$1.65M | SELL | -6.10% | 504.437K | Sep 22 - Sep 24 | View |
| Sep 21, 2021 | Elena Prokupets | DIRECTOR | -21.161K | $50.09 | -$1.06M | SELL | -3.86% | 526.364K | Sep 17 - Sep 21 | View |
| Sep 21, 2021 | Malcolm Salter | DIRECTOR | -755 | $49.89 | -$37.67K | SELL | -5.52% | 12.917K | Sep 17 | View |
| Sep 16, 2021 | Elena Prokupets | DIRECTOR | -81.676K | $48.78 | -$3.98M | SELL | -13.80% | 510.385K | Sep 14 - Sep 16 | View |
| Sep 14, 2021 | Elena Prokupets | DIRECTOR | -9.21K | $50.05 | -$460.98K | SELL | -1.54% | 588.223K | Sep 10 - Sep 13 | View |
| Sep 14, 2021 | Jolie Siegel | CHIEF LEGAL OFFICER | 0 | $27.49 | -$562.75K | SELL-OPTIONS | 0.00% | 0 | Sep 10 | View |
| Aug 24, 2021 | Malcolm Salter | DIRECTOR | -755 | $40.73 | -$30.75K | SELL | -5.23% | 13.672K | Aug 20 | View |
| Aug 05, 2021 | Elena Prokupets | DIRECTOR | -14.407K | $45.16 | -$650.59K | SELL | -2.07% | 681.447K | Aug 03 | View |
| Aug 05, 2021 | Stewart Fisher | CHIEF SCIENTIFIC OFFICER | -17.057K | $45.01 | -$767.81K | SELL | -42.86% | 22.744K | Aug 03 | View |
| Aug 02, 2021 | Jolie Siegel | CHIEF LEGAL OFFICER | 0 | $24.99 | -$500.25K | SELL-OPTIONS | 0.00% | 0 | Jul 29 | View |
| Aug 02, 2021 | Elena Prokupets | DIRECTOR | -15.593K | $45.01 | -$701.77K | SELL | -2.19% | 695.854K | Jul 29 - Aug 02 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.